Avmapki™ Fakzynja™ Co-Pack (avutometinib; defactinib) – New orphan drug approval
May 8, 2025 - The FDA announced the approval of Verastem’s Avmapki Fakzynja Co-Pack (avutometinib; defactinib), for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.
Top